Resectable pancreatic ductal adenocarcinoma

What changed: Resectable pancreatic ductal adenocarcinoma

Cancer page →

Every dated change on the records linked to Resectable pancreatic ductal adenocarcinoma, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.

Trial result3Milestone7This record1

FollowWatch this cancer and Saved shows what changed since you last looked.Follow by feed

September 2026 · 1

2026-09-18This recordResectable pancreatic ductal adenocarcinoma
Facts on this page last checked
When this page itself was last checked or edited.

2026 · 1

2026Trial resultAMPLIFY-7P
AMPLIFY-7P reported
Primary DFS endpoint not met.

2024 · 1

2024MilestoneFOLFIRINOX / mFOLFIRINOX
NORPACT-1: neoadjuvant FOLFIRINOX does not lengthen survival in clearly resectable disease
A milestone in how this cancer is treated.

2023 · 1

2023MilestoneAutogene cevumeran
Autogene cevumeran phase 1: personalised mRNA vaccine after surgery raises T cells that track with staying recurrence-free
A milestone in how this cancer is treated.

2022 · 1

2022Trial resultPREOPANC-1 / PREOPANC-2
PREOPANC-1 / PREOPANC-2 reported
PREOPANC-1 5-year OS 20.

2020 · 1

2020MilestonePREOPANC-1 / PREOPANC-2
PREOPANC-1: neoadjuvant chemoradiation before surgery improves long-term survival in resectable and borderline disease
A milestone in how this cancer is treated.

2018 · 2

2017 · 1

2017MilestoneGemcitabine
ESPAC-4: gemcitabine plus capecitabine beats gemcitabine alone after surgery
A milestone in how this cancer is treated.

2007 · 1

2007MilestoneGemcitabine
CONKO-001: adjuvant gemcitabine after resection lengthens disease-free survival
A milestone in how this cancer is treated.

1935 · 1

1935MilestoneWhipple procedure (pancreaticoduodenectomy)
Allen Whipple describes the pancreatoduodenectomy that carries his name
A milestone in how this cancer is treated.